Royalty Pharma EVP Hite acquires 7,122 award shares

Family vehicles controlled by the EVP & Chairman, Partnering hold interests exchangeable into Class A shares; RPH Class E shares are subject to vesting conditions.

Available on EDGAR 11/06/2026 - 04:14 PM EST Accepted by SEC EDGAR 11/06/2026 - 04:13 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Royalty Pharma plc (RPRX) reports an award-related acquisition of 7,122 Class A Ordinary Shares on November 4, 2026, held indirectly through SCH Investment Partners LLC for reporting person Christopher Hite, EVP & Chairman, Partnering. The acquisition was in connection with settlement of Equity Performance Awards.

The reported post-transaction positions were 277,523 shares held indirectly and 23,200 shares held directly. Family vehicles controlled by Hite hold interests exchangeable into 866,410 Class A Ordinary Shares through RPI US Partners 2019, LP and RPH Class E Ordinary Shares exchangeable into 1,238,789 Class A Ordinary Shares; the Class E shares are subject to vesting conditions.

Insider Trade Summary

Grant/Award: 7,122 shares

Grant/Award 1 txn

Insider Hite Christopher

Role EVP & Chairman, Partnering

Type	Security	Shares	Price	Value
Grant/Award	Class A Ordinary Shares F1	7,122	$0.00	$0.00
Holding	Class A Ordinary Shares	--	--	--

Holdings After Transaction: Class A Ordinary Shares — 277,523 shares (Indirect, By SCH Investment Partners LLC); Class A Ordinary Shares — 23,200 shares (Direct)

Footnotes (1)

1. F1. Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.

Key Figures

Award-related acquisition: 7,122 Class A Ordinary Shares Indirect holdings after transaction: 277,523 shares Direct holdings: 23,200 shares +2 more

5 metrics

Award-related acquisition 7,122 Class A Ordinary Shares Indirect acquisition on November 4, 2026, through SCH Investment Partners LLC

Indirect holdings after transaction 277,523 shares Reported after the November 4, 2026 transaction; held through SCH Investment Partners LLC

Direct holdings 23,200 shares Reported as of November 4, 2026

Class A shares exchangeable through limited partnership interests 866,410 Class A Ordinary Shares Interests held by family vehicles in RPI US Partners 2019, LP

Class A shares exchangeable through RPH Class E shares 1,238,789 Class A Ordinary Shares Family-vehicle holdings; the Class E Ordinary Shares are subject to vesting conditions

Key Terms

Equity Performance Awards, Rule 16b-3, limited partnership interests, Class E Ordinary Shares

4 terms

Equity Performance Awards technical

"settlement of Equity Performance Awards"

Rule 16b-3 regulatory

"pursuant to Rule 16b-3"

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

limited partnership interests financial

"hold limited partnership interests in RPI US Partners 2019, LP"

An ownership stake in a limited partnership gives an investor the role of a limited partner who provides capital but does not run day-to-day operations; a separate general partner manages the business. It matters because limited partners share profits, losses, and tax benefits but generally cannot lose more than they invested and have little control or liquidity—think of it like quietly funding a small business while someone else manages it, with potential return and risk tied to the venture’s performance.

Class E Ordinary Shares technical

"Class E Ordinary Shares of RPH"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RPRX shares were acquired through SCH Investment Partners LLC?

SCH Investment Partners LLC was reported as holding 7,122 Class A Ordinary Shares acquired indirectly on November 4, 2026, in connection with settlement of Equity Performance Awards.

Why was the RPRX share acquisition reported as an award transaction?

The acquisition was reported as an exempt acquisition pursuant to Rule 16b-3 in connection with settlement of Equity Performance Awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hite Christopher

(Last) (First) (Middle)

C/O ROYALTY PHARMA PLC

110 E. 59TH STREET

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Royalty Pharma plc [ RPRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chairman, Partnering

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Ordinary Shares	11/04/2026		A		7,122(1)	A	$0	277,523	I	By SCH Investment Partners LLC
Class A Ordinary Shares								23,200	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.

Remarks:

In addition to the Class A Ordinary Shares disclosed above, family vehicles controlled by the Reporting Person hold limited partnership interests in RPI US Partners 2019, LP exchangeable into 866,410 Class A Ordinary Shares and Class E Ordinary Shares of Royalty Pharma Holdings Ltd ("RPH") exchangeable into 1,238,789 Class A Ordinary Shares. Class E Ordinary Shares of RPH are subject to vesting conditions.

	/s/ Sean Weisberg, as Attorney-in-Fact for Christopher Hite	11/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)